|
End-of-day quote
Pakistan S.E.
2026-10-01
|
5-day change | 1st Jan Change | ||
| 929.50 PKR | -0.38% |
|
-3.10% | -9.09% |
| Fiscal Period: December | 2016 (PKR) | 2017 (PKR) | 2018 (PKR) | 2019 (PKR) | 2020 (PKR) | 2021 (PKR) | 2022 (PKR) | 2023 (PKR) | 2024 (PKR) | 2025 (PKR) |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 19.11 | 20.74 | 16.43 | 19.54 | 21.54 | |||||
Return on Total Capital | 25.31 | 27.23 | 21.13 | 25.29 | 28.49 | |||||
Return On Equity % | 35.33 | 36.44 | 27.67 | 31.04 | 32.32 | |||||
Return on Common Equity | 35.33 | 36.44 | 27.67 | 31.04 | 32.32 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 50.2 | 51.79 | 47.55 | 50.82 | 54.83 | |||||
SG&A Margin | 30.65 | 29.4 | 28.94 | 28.33 | 29.97 | |||||
EBITDA Margin % | 19.08 | 21.45 | 18.09 | 21.32 | 24.03 | |||||
EBITA Margin % | 17.8 | 20.29 | 17.09 | 20.29 | 22.8 | |||||
EBIT Margin % | 17.79 | 20.29 | 17.09 | 20.29 | 22.8 | |||||
Income From Continuing Operations Margin % | 14.28 | 15.63 | 12.38 | 13.76 | 14.9 | |||||
Net Income Margin % | 14.28 | 15.63 | 12.38 | 13.76 | 14.9 | |||||
Net Avail. For Common Margin % | 14.28 | 15.63 | 12.38 | 13.76 | 14.9 | |||||
Normalized Net Income Margin | 11.63 | 13.51 | 10.52 | 12.09 | 14.08 | |||||
Levered Free Cash Flow Margin | 9.02 | -9.36 | 3.21 | 16.2 | 6.43 | |||||
Unlevered Free Cash Flow Margin | 9.15 | -9.13 | 3.68 | 17.21 | 6.68 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.72 | 1.64 | 1.54 | 1.54 | 1.51 | |||||
Fixed Assets Turnover | 7.23 | 7.5 | 6.1 | 6.18 | 6.68 | |||||
Receivables Turnover (Average Receivables) | 28.73 | 15.62 | 11.3 | 10.73 | 8.12 | |||||
Inventory Turnover (Average Inventory) | 2.79 | 2.36 | 2.16 | 2.35 | 2.21 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.76 | 3.31 | 3.43 | 3.02 | 3.03 | |||||
Quick Ratio | 2.09 | 1.35 | 1.63 | 1.81 | 1.73 | |||||
Operating Cash Flow to Current Liabilities | 1.01 | -0.16 | 0.55 | 1.01 | 0.37 | |||||
Days Sales Outstanding (Average Receivables) | 12.7 | 23.37 | 32.29 | 34.11 | 44.95 | |||||
Days Outstanding Inventory (Average Inventory) | 130.6 | 154.64 | 168.67 | 155.55 | 165.17 | |||||
Average Days Payable Outstanding | 11.67 | 18.83 | 26.06 | 41.45 | 50.74 | |||||
Cash Conversion Cycle (Average Days) | 131.63 | 159.18 | 174.9 | 148.21 | 159.38 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 6.33 | 10.29 | 14.98 | 11.6 | 5.83 | |||||
Total Debt / Total Capital | 5.96 | 9.33 | 13.03 | 10.39 | 5.51 | |||||
LT Debt/Equity | 2.02 | 2.6 | 9 | 3.3 | 2.79 | |||||
Long-Term Debt / Total Capital | 1.9 | 2.36 | 7.82 | 2.95 | 2.63 | |||||
Total Liabilities / Total Assets | 28.52 | 30.13 | 31.93 | 31.55 | 29.24 | |||||
EBIT / Interest Expense | 84.3 | 56.24 | 22.64 | 12.65 | 55.41 | |||||
EBITDA / Interest Expense | 91.49 | 60.03 | 24.42 | 13.53 | 59.07 | |||||
(EBITDA - Capex) / Interest Expense | 81.35 | 45.4 | 19.14 | 12.9 | 55.08 | |||||
Total Debt / EBITDA | 0.15 | 0.23 | 0.41 | 0.26 | 0.12 | |||||
Net Debt / EBITDA | -1 | -0.24 | -0.24 | -0.7 | -0.42 | |||||
Total Debt / (EBITDA - Capex) | 0.17 | 0.3 | 0.53 | 0.27 | 0.13 | |||||
Net Debt / (EBITDA - Capex) | -1.12 | -0.32 | -0.31 | -0.74 | -0.45 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 21.53 | 21.65 | 24.98 | 24.6 | 12.44 | |||||
Gross Profit, 1 Yr. Growth % | 24.48 | 25.5 | 14.75 | 33.19 | 22.46 | |||||
EBITDA, 1 Yr. Growth % | 20.06 | 36.78 | 5.43 | 34.37 | 26.75 | |||||
EBITA, 1 Yr. Growth % | 19.42 | 38.74 | 5.24 | 34.69 | 26.42 | |||||
EBIT, 1 Yr. Growth % | 19.43 | 38.75 | 5.25 | 34.69 | 26.42 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 25.96 | 33.2 | -1.01 | 38.44 | 21.83 | |||||
Net Income, 1 Yr. Growth % | 25.96 | 33.2 | -1.01 | 38.44 | 21.83 | |||||
Normalized Net Income, 1 Yr. Growth % | 23.27 | 41.32 | -2.65 | 41.44 | 30.96 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 25.96 | 33.2 | -1.01 | 38.44 | 21.83 | |||||
Accounts Receivable, 1 Yr. Growth % | 80.54 | 91.5 | 62.9 | 11.83 | 81.58 | |||||
Inventory, 1 Yr. Growth % | 12.26 | 63.69 | 18.12 | -1.61 | 21.82 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2.92 | 31.31 | 70.57 | -4.72 | 13.08 | |||||
Total Assets, 1 Yr. Growth % | 20.86 | 30.59 | 34.56 | 16.87 | 12.8 | |||||
Tangible Book Value, 1 Yr. Growth % | 28.41 | 29.25 | 31.29 | 17.44 | 16.74 | |||||
Common Equity, 1 Yr. Growth % | 28.85 | 29.38 | 31.1 | 17.53 | 16.6 | |||||
Cash From Operations, 1 Yr. Growth % | 21.57 | -123.55 | -521.54 | 162.81 | -58.55 | |||||
Capital Expenditures, 1 Yr. Growth % | -24.27 | 200.04 | -5.63 | -68.55 | 83.67 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 41.62 | -226.23 | -143.62 | 373.97 | -55.38 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 40.95 | -221.41 | -151.29 | 353.11 | -56.3 | |||||
Dividend Per Share, 1 Yr. Growth % | 46.67 | 10 | 89.75 | 33.33 | 25 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 19.87 | 21.59 | 23.3 | 24.79 | 18.39 | |||||
Gross Profit, 2 Yr. CAGR % | 24.17 | 24.99 | 20 | 23.63 | 27.14 | |||||
EBITDA, 2 Yr. CAGR % | 31.45 | 28.15 | 20.09 | 24.43 | 30.5 | |||||
EBITA, 2 Yr. CAGR % | 32.32 | 28.72 | 20.83 | 24.77 | 30.49 | |||||
EBIT, 2 Yr. CAGR % | 32.33 | 28.73 | 20.84 | 24.78 | 30.49 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 36.21 | 29.53 | 14.83 | 17.06 | 29.87 | |||||
Net Income, 2 Yr. CAGR % | 36.21 | 29.53 | 14.83 | 17.06 | 29.87 | |||||
Normalized Net Income, 2 Yr. CAGR % | 34.07 | 31.99 | 17.29 | 18.09 | 36.12 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 36.21 | 29.53 | 14.83 | 17.06 | 29.87 | |||||
Accounts Receivable, 2 Yr. CAGR % | 22.01 | 103.09 | 76.63 | 34.97 | 42.5 | |||||
Inventory, 2 Yr. CAGR % | 15.7 | 35.55 | 45.52 | 7.8 | 9.48 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 14.84 | 16.25 | 49.66 | 27.48 | 3.8 | |||||
Total Assets, 2 Yr. CAGR % | 32.27 | 26.48 | 32.56 | 25.41 | 14.82 | |||||
Tangible Book Value, 2 Yr. CAGR % | 30.79 | 28.83 | 30.27 | 24.18 | 17.09 | |||||
Common Equity, 2 Yr. CAGR % | 31 | 29.11 | 30.23 | 24.13 | 17.06 | |||||
Cash From Operations, 2 Yr. CAGR % | 53.84 | -46.49 | -0.41 | 230.53 | 4.37 | |||||
Capital Expenditures, 2 Yr. CAGR % | 2.53 | 50.74 | 68.27 | -45.52 | -23.99 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 94.71 | 33.7 | -26.43 | 65.64 | 45.42 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 90.48 | 30.82 | -21.78 | 72.82 | 40.71 | |||||
Dividend Per Share, 2 Yr. CAGR % | 36.44 | 27.02 | 44.47 | 59.06 | 29.1 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 20.11 | 20.46 | 22.71 | 23.74 | 20.55 | |||||
Gross Profit, 3 Yr. CAGR % | 22.63 | 24.62 | 21.48 | 24.25 | 22.87 | |||||
EBITDA, 3 Yr. CAGR % | 28.62 | 33.2 | 20.08 | 28.42 | 25.2 | |||||
EBITA, 3 Yr. CAGR % | 29.82 | 34.43 | 20.36 | 29.26 | 25.32 | |||||
EBIT, 3 Yr. CAGR % | 30.03 | 34.44 | 20.37 | 29.27 | 25.32 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 36.36 | 35.2 | 18.42 | 22.21 | 18.63 | |||||
Net Income, 3 Yr. CAGR % | 36.36 | 35.2 | 18.42 | 22.21 | 18.63 | |||||
Normalized Net Income, 3 Yr. CAGR % | 32.06 | 36.45 | 19.25 | 25.38 | 22.25 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 36.36 | 35.2 | 18.42 | 22.21 | 18.63 | |||||
Accounts Receivable, 3 Yr. CAGR % | 27.42 | 50.38 | 88.7 | 51.67 | 49 | |||||
Inventory, 3 Yr. CAGR % | 21.45 | 29.88 | 33.46 | 27.72 | 12.29 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 13.26 | 20.08 | 32.1 | 28.75 | 22.49 | |||||
Total Assets, 3 Yr. CAGR % | 29.06 | 32.3 | 29.12 | 27.11 | 21.05 | |||||
Tangible Book Value, 3 Yr. CAGR % | 27.49 | 30.28 | 29.64 | 25.84 | 21.65 | |||||
Common Equity, 3 Yr. CAGR % | 27.61 | 30.46 | 29.77 | 25.85 | 21.57 | |||||
Cash From Operations, 3 Yr. CAGR % | 54.01 | -17.7 | 6.43 | 36.98 | 65.44 | |||||
Capital Expenditures, 3 Yr. CAGR % | 34.99 | 46.66 | 28.95 | -3.79 | -18.31 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 60.75 | 68.52 | -8.48 | 50.44 | 6.97 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 59.76 | 63.93 | -4.81 | 52.73 | 9.28 | |||||
Dividend Per Share, 3 Yr. CAGR % | 26.99 | 26.99 | 45.2 | 40.66 | 46.78 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 20.72 | 21.51 | 21.38 | 22.18 | 20.96 | |||||
Gross Profit, 5 Yr. CAGR % | 22.37 | 23.49 | 21.57 | 24.22 | 23.71 | |||||
EBITDA, 5 Yr. CAGR % | 23.1 | 28.01 | 25.14 | 29.62 | 26.37 | |||||
EBITA, 5 Yr. CAGR % | 23.84 | 28.92 | 26.14 | 30.48 | 26.67 | |||||
EBIT, 5 Yr. CAGR % | 24.33 | 29.36 | 26.28 | 30.49 | 26.67 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 28.72 | 32.31 | 27.3 | 27.63 | 22.88 | |||||
Net Income, 5 Yr. CAGR % | 28.7 | 32.31 | 27.3 | 27.63 | 22.88 | |||||
Normalized Net Income, 5 Yr. CAGR % | 25.61 | 31.03 | 25.94 | 28.79 | 26.05 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 28.7 | 32.31 | 27.3 | 27.63 | 22.88 | |||||
Accounts Receivable, 5 Yr. CAGR % | 50.61 | 39.63 | 50.41 | 44.02 | 68.65 | |||||
Inventory, 5 Yr. CAGR % | 19.81 | 28.88 | 30.56 | 22.77 | 23.3 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 14.19 | 14.29 | 26.61 | 22.99 | 19.95 | |||||
Total Assets, 5 Yr. CAGR % | 23.19 | 25.94 | 30.8 | 29.5 | 23.2 | |||||
Tangible Book Value, 5 Yr. CAGR % | 27.08 | 26.21 | 28.59 | 27.8 | 24.47 | |||||
Common Equity, 5 Yr. CAGR % | 26.85 | 26.25 | 28.66 | 27.89 | 24.53 | |||||
Cash From Operations, 5 Yr. CAGR % | 22.14 | 7.94 | 29.37 | 43.49 | 5.31 | |||||
Capital Expenditures, 5 Yr. CAGR % | 7.45 | 40 | 47.43 | -1.31 | 4.37 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 24.42 | 84.27 | 17.59 | 66.79 | 16.56 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 24.64 | 81.92 | 20.06 | 66.84 | 17.02 | |||||
Dividend Per Share, 5 Yr. CAGR % | 31.48 | 26.81 | 33.71 | 38.96 | 38.53 |
- Stock Market
- Stocks
- HINOON Stock
- Financials Highnoon Laboratories Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















